Chemours
460 hedge funds and large institutions have $3.55B invested in Chemours in 2021 Q3 according to their latest regulatory filings, with 62 funds opening new positions, 136 increasing their positions, 135 reducing their positions, and 46 closing their positions.
35% more first-time investments, than exits
New positions opened: 62 | Existing positions closed: 46
2% more funds holding
Funds holding: 449 → 460 (+11)
1% more repeat investments, than reductions
Existing positions increased: 136 | Existing positions reduced: 135
0% more funds holding in top 10
Funds holding in top 10: 7 → 7 (0)
0.99% less ownership
Funds ownership: 75.08% → 74.1% (-0.99%)
18% less capital invested
Capital invested by funds: $4.31B → $3.55B (-$759M)
89% less call options, than puts
Call options by funds: $41.6M | Put options by funds: $370M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Northern Trust
Chicago,
Illinois
|
+$24.8M |
| 2 |
LM
Luminus Management
Houston,
Texas
|
+$21.9M |
| 3 |
Prudential Financial
Newark,
New Jersey
|
+$18.6M |
| 4 |
Renaissance Technologies
New York
|
+$17.3M |
| 5 |
Millennium Management
New York
|
+$16.8M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$129M |
| 2 |
Allianz Asset Management
Munich,
Germany
|
-$83.8M |
| 3 |
Invesco
Atlanta,
Georgia
|
-$19.9M |
| 4 |
Norges Bank
Oslo,
Norway
|
-$19.8M |
| 5 |
MVP
Miller Value Partners
Sarasota,
Florida
|
-$16.6M |
CC Hedge Fund Activity: Q3 2021 in Review
460 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Chemours (CC) for Q3 2021, worth a combined $3.55B — down 18% from $4.31B a quarter earlier.
Buyers outnumbered sellers: 62 funds opened new CC positions and 46 closed out — a net gain of 16 holders — while 136 added to existing stakes and 135 trimmed.
The largest buyer was Northern Trust, adding an estimated $24.8M. The largest seller was Fidelity Investments, cutting an estimated $129M.
- 460 institutional investors held Chemours (CC) as of Q3 2021, up from 449 in Q2 2021.
- Funds reported $3.55B of Chemours stock for Q3 2021, down 18% quarter-over-quarter.
- 62 funds opened new Chemours positions in Q3 2021 and 46 closed out, a net change of +16 holders.
- The largest Chemours buyer in Q3 2021 was Northern Trust, an estimated $24.8M added.
- The largest Chemours seller in Q3 2021 was Fidelity Investments, an estimated $129M sold.
Based on aggregated 13F filings for Q3 2021.